Peter Kolchinsky on Where Drug-Pricing Policy Solutions Go Wrong
REDEEMING VALUE - OCTOBER 2020
Peter Kolchinsky, PhD
Peter Kolchinsky, RA Capital's founder and managing partner, joins to talk about why so many of the policy ideas floated around drug-pricing are wrongheaded. Industry is going to have to give "a pound of flesh," Kolchinsky argued, and he's explicit on the business practices biopharma must abandon to get a fair system that still rewards innovation.